Assignee
VOLUTION IMMUNO PHARMACEUTICALS SA
CH·5 granted patents·21 pending applications·11 citations·filing 2015–2024
Top patents by PatentIndex Score
26 records- 0181US11052129B2Ornithodoros moubata complement inhibitor for use in the treatment of complement-mediated diseases in patients with C5 polymorphismVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2015·Granted Jul 6, 2021·3 cites·30 claims
- 0280US11730792B2Coversin (OmCI) for the treatment of autoimmune blistering diseases: bullous pemphigoid (BP) and epidermolysis bullosa acquisita (EBA)VOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2018·Granted Aug 22, 2023·3 cites·21 claims
- 0377US9834585B2Method of inhibiting C5 cleavageVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2015·Granted Dec 5, 2017·2 cites·39 claims
- 0476US2022363726A1Method of Inhibiting C5 CleavageVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2022·Application pending·0 cites
- 0574US2025195612A1Coversin for use in the treatment of rheumatic diseasesVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2024·Application pending·0 cites
- 0672US9522171B2EV576 for use in the treatment of viral infections of the respiratory tractVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2015·Granted Dec 20, 2016·2 cites·28 claims
- 0771US11214602B2Coversin variants lacking C5 bindingVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2018·Granted Jan 4, 2022·1 cites·48 claims
- 0871US2022249608A1Method of Treating Peripheral Nerve DisordersVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2021·Application pending·0 cites
- 0966US2021244792A1Method of Treating Respiratory DisordersVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2021·Application pending·0 cites
- 1064US2024009270A1Coversin for the treatment of autoimmune blistering diseasesVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2023·Application pending·0 cites
- 1162US2023002456A1Coversin Variants Lacking C5 BindingVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2021·Application pending·0 cites
- 1262US2022047673A1Coversin for Use in the Treatment of Rheumatic DiseasesVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2019·Application pending·0 cites
- 1361US2021283221A1Ornithodoros Moubata Complement Inhibitor for Use in the treatment of Complement-Mediated Diseases in Patients with C5 PolymorphismVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2021·Application pending·0 cites
- 1458US2019117730A1Method of Treating Peripheral Nerve DisordersVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2018·Application pending·0 cites
- 1557US2018127472A1Method of inhibiting c5 cleavageVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2017·Application pending·0 cites
- 1655US2020282018A1Method of Treating Myasthenia GravisVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2019·Application pending·0 cites
- 1755US2020155646A1EV576 For Use in the Treatment of Viral Infections of the Respiratory TractVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2019·Application pending·0 cites
- 1853US2016166640A1Method of treating myasthenia gravisVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2015·Application pending·0 cites
- 1952US2018221440A1Method of treating respiratory disordersVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2017·Application pending·0 cites
- 2051US2016166641A1Method of treating peripheral nerve disordersVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2015·Application pending·0 cites
- 2150US2018193417A1Ornithodoros moubata complement inhibitor for use in the treatment of acute graft versus host diseaseVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2015·Application pending·0 cites
- 2248US2022370556A1Method of TreatmentVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2019·Application pending·0 cites
- 2347US2017065677A1Ev576 for use in the treatment of viral infections of the respiratory tractVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2016·Application pending·0 cites
- 2441US2021113658A1Coversin for the treatment of cicatrising eye inflammatory disordersVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2018·Application pending·0 cites
- 2541US2021171588A1Methods For Treatment of Neuropathic PainVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2018·Application pending·0 cites
- 2639US2022211810A1Method of TreatmentVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when VOLUTION IMMUNO PHARMACEUTICALS SA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →